Skip to content

Clinical Study of Mudgaparni on Vatarakta

Phytochemical Study and Therapeutic Evaluation of Mudgaparni (Vigna trilobata Linn.) for its Vataraktahara action - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/078823
Enrollment
58
Registered
2024-12-31
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E790- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease

Interventions

None listed

Sponsors

Ayurvedic and Unani Tibbia College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patient of either sex belong to age group 20-60 years. 2 Diagnosed cases of Vatarakta with classical symptoms such as Shula,Saruka shotha, Kandu, Vidaha, Sparshasahishnuta. 3 Serum Uric Acid level more than 7mg/dl for Male and more than 6mg/dl for Female. 4 Patient willing to participate in Trial and give written informed consent.

Exclusion criteria

Exclusion criteria: 1 Serum Uric Acid level more than 10mg/dl. 2 Diagnosed cases of Inflammatory Joint Disorders such as Rheumatoid Arthritis, Osteoartritis, Psoriatic Arthritis. 3 Patients suffering from Chronic Renal Impairment, Chronic Respiratory Diseases, Hepatic Disease. 4 Pregnant and Lactating patients. 5 Patients taking Steroid therapy. 6 Patients taking any form of Medication for Hyperuricemia.

Design outcomes

Primary

MeasureTime frame
Serum Uric Acid level less than 6mg/dl will be considered as Healthy individualsTimepoint: 3 Months

Secondary

MeasureTime frame
For Assessing the effectiveness of treatment, the scoring pattern of Subjective & Objective parameters will be assessed before & after treatmentTimepoint: Before & After Completion of Trial

Countries

India

Contacts

Public ContactDr. Rajesh Sharma

Ayurvedic and Unani Tibbia College and Hospital

rajsakshi.sharma@gmail.com9868092250

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026